BIIB Related Trader Talk
-
Vivus (VVUS) Sees Upside on Icahn Connection
-
Biogen Idec (BIIB) Pops on Strong Tecfidera Rx Growth
-
XenoPort (XNPT) Pops Higher on Biogen (BIIB) Tecfidera Approval
-
Teva (TEVA) Hits Session Lows as Biogen (BIIB) MS Pill Gains Approval
-
UPDATE: Biogen Idec (BIIB) wins FDA approval for MS pill
-
UPDATE: Bristol-Myers (BMY) Considered Deals for Biogen (BIIB), Shire (SHPG) - DJN
-
Stocks Crossing 50-Day SMA 02/06: (NOK) (FSLR) (VRNG) Above; (ELN) (SU) (AINV) Below
-
Biogen Idec (BIIB) Sinks 8% After ALS Drug Fails, Development Stopped
-
Elan Corp. (ELN) Active Following Large Block Trade; Traders Mull Market Chatter
-
Q2 Kickoff: Alcoa (AA) Investors to Focus on LME Prices, Downstream Ops, and China
-
Elan Corp (ELN) Has Mutlipe Items Driving Action Today
-
Traders Watching Regeneron (REGN) Following Amgen (AMGN) AMG 145 Results
-
Elan (ELN) Pops Higher, Possibly Ahead of Gilenya Safety Review
-
Alexion Pharmaceuticals (ALXN) Lower As Biotechs See Pressure
-
Corporate Earnings for Q1 Look Promising So Far, Here's the Top Movers...
-
Pre-Open Movers 4/21: (TRAD) (BIIB) (AAPL) Higher; (TEVA) (SINA) (CMG) Lower (more...)
-
Teva Pharmaceutical (TEVA) Slammed On Strong BG-12 Trial Data from Biogen (BIIB)
-
Pre-Open Movers 4/11: (GLBC) (AMMD) (TYC) Higher; (CELM) (SHAW) (SINA) Lower
-
Biotech Stocks Could See Action On Valeant (VRX) Bid for Cephalon (CEPH): (BIIB) (JAZZ) (DNDN) (REGN) (more...)
-
Icahn Gives Seal of Approval to Biogen (BIIB); Skips Director Nomination
-
Goldman Sachs Starts AMGN & BIIB at 'Sell', CELG & GILD at 'Neutral', and ALXN at Conviction Buy
-
Biogen Idec (BIIB) Falls Following FDA Okay for Novartis' MS Drug Gilenya
-
Carl Icahn Shows New Stakes In Energy Names and a Gun Maker (APC, NRG, SWHC)
-
Wall Street Hubbub 7/26: A Genzyme (GENZ) Deal Coming, Is Biogen Idec (BIIB) Next, New BP CEO, Goldman Sachs the Movie
-
Biogen Idec (BIIB) Falls On Reports Sanofi Could Be After Genzyme
-
Wall Street Hubbub 7/21: Traders Nervous Ahead NFLX/BIDU Results, Dimon & Blankfein Not Welcome at FinReg Signing, Bernanke Set to Testify, BIIB/LLL/DTG In the Rumor Mill
-
Allergan (AGN), Biogen Idec (BIIB) Higher As sanofi-aventis Prepares for Possible Mega-Deal
-
Reports Sanofi-aventis (SNY) Planning Large U.S. Acquisition
-
Study Shows Record $65 billion Spent by U.S. Biopharmaceutical Companies in R&D
-
Biotech Rumor Mill Hopping After Hostile Bid for OSI Pharmaceuticals (OSIP)
-
FDA Issues Alert on Biogen's (BIIB) Tysabri: Continued Use Increases Risk of Developing PML
-
Elan (ELN) and Biogen (BIIB) Weak On Jump In Tysabri PML Cases
-
Elan (ELN) Issues Statement Regarding Federal Court Ruling on Tysabri Collaboration Agreement
-
Icahn's 13Fs Show No Major Changes (YHOO, MOT, BIIB, AMLN, LGF)
-
Goldman Sachs Tells Clients To Buy Biogen Idec (BIIB) on Today's Weakness
-
Biogen (BIIB) Adjourns Meeting; Will Issue Statement by End of the Day Related to Vote Results
-
Icahn To File Lawsuit To Stop Biogen Idec (BIIB) Vote
-
Biogen Idec (BIIB) Shareholder Meeting In Recess, Icahn Wants Vote Closed
-
Icahn Boosts Stake in American Railcar (ARII), Maintains Large Yahoo! (YHOO) and Motorola (MOT) Holdings
-
Biogen Idec (BIIB) up on reports of an effective drug-cleansing treatment for TYSABRI patients with PML
-
Icahn Down $60M on Healthcare Stocks This Week (AMLN, BIIB, CYBX, REGN, FOLD)
-
Icahn's Icahn Capital Bumps Stake in Motorola (MOT), Shows New Small Stake in Emisphere (EMIS)
-
Amylin Pharmaceuticals (AMLN) Could Be One To Watch On ImClone Bid
-
Biogen Idec (BIIB) Could Be One To Watch On ImClone Bid
-
Judge Rules Biogen (BIIB) Must Give Icahn Access to Sales Records -Bloomberg
-
Biogen Idec (BIIB) Tysabri linked to 'significant liver injury' FDA says- Bloomberg
-
Icahn Has a Busy Day: BEAS, WCI, More...
-
Equity option family volume leaders in first 30-minutes of Trading: MBI BIIB RIMM ORCL
-
Equity option family volume leaders in first 30-minutes of Trading: C WM LEH BIIB
-
Biogen Idec (BIIB) Slashed 25% Following Failed Sale
Back to BIIB Stock Lookup
